Elective inactivation of total artificial heart technology in non-futile situations: Inpatients, outpatients and research participants

Death Studies

Volumn 28, Issue 5, 2004, Pages 423-433

  Bramstedt, Katrina A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE EUTHANASIA; ARTIFICIAL HEART; CLINICAL PRACTICE; CLINICAL RESEARCH; DECISION MAKING; ELECTIVE SURGERY; HOSPITAL PATIENT; HUMAN; LAW; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL TECHNOLOGY; OUTPATIENT; REVIEW; TREATMENT WITHDRAWAL; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; DEATH AND EUTHANASIA;

CLINICAL TRIALS; DECISION MAKING; HEART, ARTIFICIAL; HUMANS; MENTAL COMPETENCY; PERSONAL AUTONOMY; RIGHT TO DIE; TREATMENT REFUSAL; UNITED STATES;

EID: 2542446265     PISSN: 07481187     EISSN: None     Source Type: Journal    
DOI: 10.1080/07481180490437545     Document Type: Review

References (23)

1. AbioCor. (2001). Clinical trial information. Retrieved December 11, 2001, from http://www.abiomed.com/Fabiocor.html.
2. Abiomed, Inc. (2003). Clinical status update conference call: Internet broadcast. Retrieved April 29, 2003, from http://www.abiomed.com
3. American Medical Association. (1994). Policy E2.035, Futile Care. Retrieved October 1, 2002, from http://www.ama-assn.org
4. Beauchamp, T. L. & Childress, J. F. (1994). Principles of biomedical ethics (pp. 127-128). New York: Oxford University Press.
5. Bramstedt, K. A. (2001). The use of advance directives and do not resuscitate orders when considering the inactivation of implantable cardioverter-defibrillators in terminal patients. Cardiovascular Reviews & Reports, 22, 175-76.
6. Bramstedt, K. A. (2003a). Contemplating total artificial heart inactivation in cases of futility. Death Studies, 27, 295-304.
7. Bramstedt, K. A. (2003b). Replying to Veatch's concerns: Special moral problems with total artificial heart inactivation. Death Studies, 27, 317-320.
8. Bramstedt, K. A. & Wenger, N. S. (2001). When the withdrawal of life-sustaining care does more than allow death to take its course: The dilemma of left ventricular assist devices. Journal of Heart and Lung Transplantation, 20, 544-548.
9. British Medical Association. (1999). Withholding and withdrawing life-prolonging medical treatment: Guidance for decision making. London: BMJ Books.
10. Brody, H., Campbell, M. L., Faber-Langendoen, K., & Ogle, K. S. (1997). Withdrawing intensive life-sustaining treatment-recommendations for compassionate clinical management. New England Journal of Medicine, 336, 652-657.
11. Callahan, D. (1996). Specifying the goals of medicine. Hastings Center Report, 6, S9-S14.
12. DeVries, W. C. (1988). The permanent artificial heart: Four case reports. Journal of the American Medical Association, 259, 849-859.
13. Jonsen, A. R., Siegler, M., & Winslade, W. J. (1992). Clinical ethics: A practical approach to ethical decisions in clinical medicine. New York: McGraw-Hill.
14. Miles, S. H., Siegler, M., Schiedermayer, D. L., Lantos, J. D., & LaPuma, J. (1998). The total artificial heart: An ethics perspective on current clinical research and deployment. Chest, 94, 409-413.
15. National Bioethics Advisory Commission. (1998). Research involving persons with mental disorders that may affect decisionmaking capacity. In Moving ahead in research involving persons with mental disorders: Summary and recommendations. Washington DC. Retrieved May 8, 2003, from http://bioethics.georgetown.edu/nbac/capacity/Moving.htm
16. President's Commission for the Study of Ethical Problems in Medicine and Biomedicine and Behavioral Research. (1983). Deciding to forego life-sustaining treatment: Ethical, medical, and legal issues in treatment decisions (pp. 89-90). Washington, DC: US Government Printing Office.
17. Protection of Human Subjects-Additional Elements of Informed Consent. (1991). United States Title 45 Code of Federal Regulations Section 46.116(b)4.
18. Protection of Human Subjects-Basic Elements of Informed Consent. (1991). United States Title 45 Code of Federal Regulations Section 46.116(a)8.
19. Protection of Human Subjects-Criteria for IRB Approval of Research. (1991). United States Title 45 Code of Federal Regulations Section 46.111(b).
20. Protection of Human Subjects-Definitions. (1991). United States Title 45 Code of Federal Regulations Section 46.102(d).
21. Rachels, J. (1983). Barney Clark's key. Hastings Center Report, 13, 17-19.
22. Rhymes, J. A., McCullough, L. B., Luchi, R. J., Teasdale, T. A., &Wilson N. (2000). Withdrawing very low-burden interventions in chronically ill patients. Journal of the American Medical Association, 283, 1061-63.
23. United Press International. (1982 December). Suffering patient has choice to end it by using the key. Press Release.